|
A Retrospective Qualitative Study on Pharmacotherapeutic Management of Coronary Artery Disease Associated Diabetes Mellitus and Discussion on Comprehensive Role of Clinical Pharmacist In Clinical Practice
|
|
| Author:
|
A.BHARATH KUMAR, M.S.UMASHANKAR
|
| Abstract:
|
Background: Diabetes is a group of metabolic disorders manifest with persistent hyperglycemia, associated with complications extends to 2-4 folds risk of cardiovascular diseases. The aim of the study was to evaluate the management of atherosclerotic cardiovascular diseases in diabetic patients, necessity of clinical pharmacist care services in prevention and management of coronary artery disease in diabetic patients. Methods: In this retrospective study, medical records of 200 patients diagnosed with coronary artery disease in type 2 diabetes were selected according to inclusion and exclusion criteria. The study was carried out in the SRM tertiary care hospital medical records department after due approval for a period of six months. Results: The present study revealed that the coronary artery disease in diabetes was more prevalent in age group between 51-60 years. About 31% patients with hyperlipidemia were at risk to develop the disease complication. The low left ventricular ejection fraction ranges from 30-35 patients were high 65(32.5%), who were at more prominent risk of the coronary artery disease. Glycated hemoglobin test was revealed that 9-12 mg/dl patients were more 108 (54%), and HDL levels less than 40 mg/dl patients were more 83 (41.5%). The study showed only 14% of patients was prescribed with Insulin and hypoglycemic agents and 11.5 % of the patients were treated with statins revealing an improved effective drug prescribing pattern was needed. Conclusion: Early integration of clinical pharmacist’s intervention is to be put forward to individual patients to improve the health condition and it can condense the hospital admissions.
|
| Keyword:
|
Coronary artery disease, diabetes mellitus, clinical pharmacist, patient care services, glycated hemoglobin, hyperlipidemia.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.502
|
| Download:
|
Request For Article
|
|
|